Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01983020 · ClinicalTrials.gov registry record · Phase 3
Peri-Operative Lidocane, Ketamine, or Lidocane and Ketamine Combination, Infusion for Patients Undergoing Spine Surgery
A Phase 3 study, sponsored by Beth Israel Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 46
- Enrollment target
NCT01983020 is a Phase 3 study that has completed, run by Beth Israel Medical Center. The registered enrollment target is 46 participants.
The verdict
NCT01983020, a Phase 3 study, has completed, sponsored by Beth Israel Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 46 participants
- Enrollment target
Study Summary
This study has been designed as a controlled clinical trial to evaluate the efficacy of brief lidocaine infusion, brief ketamine infusion and a lidocaine/ketamine combined infusion when added to conventional opioid therapy following major spine surgery, as well as to evaluate the effects of the lidocaine/ketamine pain protocol on the feasibility of performing routine intraoperative neurophysiology during spine surgery in adults and determine whether this infusion protocol is compatible with intraoperative neurophysiology on spine surgery patients. If one or more of the approaches is confirmed as efficacious and safe, it could have a significant impact on the routine management of postoperative pain in this context.
Interventions
- DRUG Ketamine
- OTHER Saline
- DRUG Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01983020
The ClinicalTrials.gov registry entry for NCT01983020 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Medical Center, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ketamine is the first listed.
NCT01983020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01983020 about?
NCT01983020 is a clinical study titled "Peri-Operative Lidocane, Ketamine, or Lidocane and Ketamine Combination, Infusion for Patients Undergoing Spine Surgery". This study has been designed as a controlled clinical trial to evaluate the efficacy of brief lidocaine infusion, brief ketamine infusion and a lidocaine/ketamine combined infusion when added to conventional opioid therapy following major spine surgery, as well as to evaluate the effects of the lido...
What is the current status of trial NCT01983020?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 46 participants. The study started on 2011-04. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01983020?
The interventions under investigation include: Ketamine (DRUG), Saline (OTHER), Lidocaine (DRUG).
Who is sponsoring clinical trial NCT01983020?
This trial is sponsored by Beth Israel Medical Center, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.